News

Next-generation weight-loss pills could hit the market in the coming months, with new data raising a key question: Will ...
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...
In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...
In 2024, I found a new primary care doctor, who promised to treat “the whole person.” She, too, urged me to keep losing ...
Lifestyle choices affect your weight, but your genes count, too. This simple hack can help tip the scales in your favor.
Weight-loss drugs are expected to pull in more than $150 billion in industry-wide revenue by the early 2030s, thanks to the ...
By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 ...
Looking to double down on weight loss? A new study says ditching this cancer-causing food group can help shed stubborn pounds ...
Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.
Weight-loss drugs significantly improve health, though they’re also tied to increased spending on other medical care that’s ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
In a clinical trial, the company's weight loss pill resulted in a nearly 12% weight loss at 72 weeks for participants who took the highest dose of the medication. On average, participants lost 7.8% to ...